Ignite Creation Date:
2024-05-06 @ 6:15 PM
Last Modification Date:
2024-10-26 @ 2:44 PM
Study NCT ID:
NCT05596266
Status:
RECRUITING
Last Update Posted:
2022-10-27
First Post:
2022-10-23
Brief Title:
CD5 CAR-T Therapy for RefractoryRelapsed CD5 T-cell Acute Lymphoblastic Leukemia
Sponsor:
Organization:
Xuanwu Hospital Beijing